ArticleEuropean journal of translational myology2025
Gifts for EJTM authors and readers and for PDM3 participants.
Article in European journal of translational myology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The summer of 2025 is approaching and the need to finalize our plans for the next few years is urgent. The next Padua Days of Muscle and Mobility Medicine (PDM3) will be held from 3 to 6 March 2026 at the Hotel Petrarca, Euganean Thermae (Padova, Italy). A preliminary flyer for 2026 PDM3 is almost ready with organizers, session schedule and keynote speakers. A new website, named Padua Muscle Days, will be soon released with all the needed information for How to Join, Registration, Accommodation, Payments and the Abstract Template for the 2026 PDM3. We hope that readers will circulate its link (www.paduamuscledays.com) among colleagues and friends. No doubt that 2026 PDM3 will be a great gift for all participants. The other novelty is the 2024 Clarivate Analytics' Impact Factor which was assigned a few days ago: 1.8. As authors who publish in other journals, but even more as reviewers, readers could contribute to making bigger a small gift. In any case, it is a gift that has been waited for decades. Four Guest Editors have done their best to make the EJTM volume 35, issue 2, 2025, a very special ssue. Indeed, it is mainly dedicated to two Thematic Sections; he first, with more works, is named Advances in Musculoskeletal and Neuromuscular Rehabilitation, by Maria Chiara Maccarone and Stefano Masiero. The second is called Generative AI for Translational Mobility Medicine, by Giorgio Fanò-Illic and Riccardo Forni, and aims to attract works that use Digital Methods for Translational Mobility Medicine. We invite the members of the EJTM editorial board and the authors of highly cited articles to follow these examples and suggest further thematic sections for the EJTM of the next decade.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.